Tata 1mg narrows healthcare loss as FY26 turnover rises 21%
Tata 1mg Healthcare reported FY26 turnover of ₹2,439.8 crore, while its net loss narrowed to ₹310 crore. The Tata Digital-owned platform is expanding diagnostics, non-metro access and rapid medicine delivery, alongside plans to raise $300 million externally.
Tata 1mg’s healthcare turnover rose 21% to ₹2,439.8 crore in FY26 as its loss narrowed to ₹310 crore. The e-pharmacy is expanding diagnostics and non-metro access, building 30-60 minute medicine delivery capabilities, and preparing for a $300 million capital raise.
Why this matters
The FY26 improvement follows Tata 1mg becoming EBITDA positive across ePharmacy, diagnostics and D2C in Q4 FY26, while its Sawaal Uthao anti-counterfeit campaign won a Cannes Bronze Lion.
Retail-company signals are accelerating, up 576850% QoQ.
Also reported by
- Mint · Companies — Same time